Myself and Kristy Piccinini, PhD from FTI Consulting published a new commentary in The Evidence Base titled “Perspectives from the Healthcare Economist: Why CMS/AHIP’s prior authorization changes won’t hurt payers.”
Dr.
Shafrin and Dr. Piccinini share their insights in this Guest Column examining
the implications of recent CMS/AHIP prior authorization reforms and why these
changes are unlikely to negatively impact payers. They explore
key questions such as:
- Who benefits most from the proposed prior authorization reform?
- Will reduced prior authorization be a good thing for society?
You can read the full article here.
Disclaimer :
This article is solely for informational purposes, any medical information contained is not a substitute for professional medical advice and readers should not rely on it as such.
If you believe there may be errors or misinformation in this article, we encourage you to contact the webmasters by messaging the provided contact information.
Your feedback is valuable, and we are committed to rectifying any inaccuracies. Please note that the content will be re-evaluated, and corrections will be made as necessary following your submission.